Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
February 02 2016 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the 18th Annual BIO CEO &
Investor Conference on Tuesday, Feb. 9, 2016, at 3:00 p.m. EST
(8:00 p.m. GMT) from the Waldorf Astoria Hotel in New York City. In
addition, Alkermes will webcast a live fireside chat, featuring
Richard Pops, at the Leerink 2016 Global Healthcare Conference on
Thursday, Feb. 11, 2016, at 12:00 p.m. EST (5:00 p.m. GMT), also
from the Waldorf Astoria Hotel in New York City. These
presentations may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160202006528/en/
Alkermes plcEva Stroynowski, +1 781 609 6823Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024